BrookfieldCME Group
Live Report · Updated 26 August 2026

Brookfield vs CME Group

Large global asset manager owning real estate and infrastructure vs Global futures and options exchange operator with clearing services. Which is the better buy for your portfolio in August 2026? Plain-English answer below.

Brookfield Asset Management runs a global alternative investment platform managing hundreds of billions across infrastructure, real estate, credit, and private equity, growing fee-related earnings as ...

Why It’s Moving

Brookfield

Brookfield’s latest results and capital moves are keeping BN in focus as investors reprice its earnings power.

  • Brookfield’s Q2 results on August 13 showed distributable earnings before realizations rose 15% year over year, signaling stronger underlying operating momentum even as reported net income remained volatile.
  • Asset management and wealth solutions continued to drive earnings growth, reinforcing the market’s view that Brookfield’s fee-based businesses are helping cushion swings from mark-to-market items and realizations.
  • The company also renewed its preferred-share buyback program on August 19, a capital-allocation move that can support investor confidence by showing management still sees value in returning capital.
Sentiment:
🐃Bullish
CME Group

CME slips as a fresh downgrade cools optimism after a strong run

  • Deutsche Bank cut CME to Hold from Buy on August 19, signaling the recent rally may have already priced in much of the good news and leaving less room for further upside.
  • The same note trimmed its valuation view, which reinforced concerns that CME’s shares are looking expensive relative to the near-term growth outlook.
  • Recent headlines around record volumes and new product launches have kept the stock supported, but investors are now weighing whether those catalysts are enough to offset the analyst downgrade and softer upside expectations.
Sentiment:
🐻Bearish

Investment Analysis

Pros

  • Brookfield Corp benefits from diversified, long-duration real asset exposure across infrastructure, renewables, real estate, and private equity, providing resilience to economic cycles.
  • The company’s global scale and presence in multiple high-growth geographies enable access to proprietary deal flow and sizeable investment opportunities not available to smaller competitors.
  • Strong institutional partnerships and substantial third-party capital under management generate recurring, high-margin asset management fees and reduce dependence on balance sheet leverage.

Considerations

  • Brookfield’s elevated leverage and debt-to-equity ratio increase sensitivity to rising interest rates and refinancing risks in volatile credit markets.
  • Complex corporate structure and multiple subsidiaries create challenges in transparency, governance, and consistent investor communication.
  • Exposure to illiquid, long-term real assets may result in valuation volatility and limited flexibility during periods of market stress or liquidity contraction.

Pros

  • CME Group operates the world’s largest and most liquid derivatives marketplace, with a near-monopoly position in key global benchmark products for interest rates, equity indices, commodities, and FX.
  • The business model is highly scalable and cash-generative, driven by high-margin electronic trading, recurring clearing revenues, and minimal operational leverage in a largely fixed-cost infrastructure.
  • Global regulatory emphasis on central clearing and risk management supports long-term structural growth in demand for CME’s core products and services.

Considerations

  • CME Group’s earnings are sensitive to trading volumes, which can fluctuate significantly with macro volatility, interest rate cycles, and investor risk appetite.
  • The company faces increasing competition from alternative trading venues, regional exchanges, and over-the-counter markets, which may erode pricing power over time.
  • Regulatory changes or shifts in clearing mandates could disrupt business flows, while market structure reforms may reduce the profitability of certain legacy products.

next-earnings-date-heading

Brookfield Corporation’s next earnings date is expected on November 12, 2026, based on the latest published earnings calendar. The report should cover Q3 2026 results. This timing is consistent with the company’s recent quarterly reporting pattern.

next-earnings-date-heading

The next earnings date for CME Group is October 28, 2026, and it is typically expected before the market opens. This report will cover Q3 2026. The timing is consistent with CME’s historical quarterly earnings cadence.

Buy BN or CME in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions